Clopivas 75mg (Clopidogrel Tablet) 75mg

Clopivas 75mg (Clopidogrel) is an antiplatelet medication used to prevent blood clots in conditions like heart disease and stroke. This 750-tablet pack helps manage cardiovascular health at ambient storage. Ideal for long-term use under medical supervision.

Strength

75mg

Pack Size

750s

Storage

Ambient

Manufacturer / TM Owner

Cipla Ltd.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Clopivas 75mg is primarily used to reduce the risk of blood clots in people with heart disease, recent stroke, or peripheral artery disease. It works by preventing platelets in the blood from sticking together, which helps maintain healthy blood flow. Patients often ask, 'what is clopidogrel 75mg used for?'—it supports conditions requiring blood clot prevention.

Side Effects

Clopivas 75mg may cause mild effects like bruising, nosebleeds, or headaches as the body adjusts. Some users report digestive discomfort or fatigue. These effects are generally temporary and do not indicate a need for medical attention unless they persist or worsen.

Precautions & Warnings

Store Clopivas 75mg at room temperature away from moisture and heat. Keep out of reach of children and pets. Inform your healthcare provider about any ongoing medications or medical conditions before use. Avoid crushing or splitting tablets unless advised by a doctor.

Avoid Interactions

Clopivas 75mg may interact with blood thinners, NSAIDs, or certain antidepressants. Alcohol use should be limited as it may increase bleeding risk. Always disclose all medications, including over-the-counter drugs, to your healthcare provider to avoid potential interactions.

Frequently Asked Questions

Clopivas 75mg is used to prevent blood clots in people with heart disease, recent stroke, or peripheral artery disease.

Store Clopivas 75mg at room temperature, away from moisture and heat, and keep it out of reach of children.

Limit alcohol use while taking Clopivas 75mg, as it may increase the risk of bleeding.

If you miss a dose, take it as soon as you remember. If it’s almost time for the next dose, skip the missed one and continue your regular schedule.

Common side effects may include bruising, nosebleeds, headaches, or digestive discomfort, but these are usually temporary.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.